Home
Clinical Resources Search
PQI: Tivozanib (Fotivda®) for Relapsed or Refractory Advanced Renal Cell Carcinoma

Tivozanib (Fotivda®) for Relapsed or Refractory Advanced Renal Cell Carcinoma

Download PQI pdf 0.18MB

Last Updated: May 3, 2024

By: Pedro C. Barata, MD

About this PQI

The purpose of this PQI is to review the clinical considerations around the use of tivozanib (Fotivda®) for patients with relapsed or refractory advanced renal cell carcinoma.

More About This PQI

PQI in Action Articles:

Tivozanib_fotivda_carcinoma pdf 1.92MB

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Find a PQI

Find Similar Resources

All Resources

PQI PQI in Action PQI Podcast Toolkit Treatment Support Kit Video Renal Cell Carcinoma (RCC) TSK Fotivda Tivozanib

PQI

Frequently Searched

Supported by

Tivozanib (Fotivda®) for Relapsed or Refractory Advanced Renal Cell Carcinoma

About this PQI

More About This PQI

PQI in Action Articles:

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

PQI: Zanidatamab-hrii (Ziihera) for the Management of Biliary Tract Cancer

PQI: Prophylaxis and Management of Skin Toxicities with Amivantamab (Rybrevant) and Lazertinib (Lazcluze) Treatment: The COCOON Protocol

PQI in Action: Fruquintinib (Fruzaqla®)

PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2

PQI in Action: Proactive Symptom Management in Myelofibrosis

PQI in Action: Sonidegib (Odomzo®) Patient Management

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

S8 Bonus Eps 2: Inside ASCO 2025

S8 E15: Supporting Survivors at Work

S8 E14: Advancing Geriatric Oncology

Readiness Tracker

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Treatment Support Kit: Temozolomide

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

S7 Ep 2: Insights on Navigating Kidney Cancer Care

Treatment Support Kit: Tivozanib

Treatment Support Kit: Cabozantinib

PQI: Cabozantinib (Cabometyx®)

Treatment Support Kit: Elranatamab

Treatment Support Kit: Mirdametinib

PQI: Temozolomide (Temodar®) for Glioblastoma Multiforme

PQI: Sorafenib (Nexavar®) for the Treatment of Hepatocellular Carcinoma and Transition to Second-line Regorafenib (Stivarga®)

Treatment Support Kit: Tivozanib

PQI in Action: Tivozanib (Fotivda®) for Relapse or Refractory Advanced Renal Cell Carcinoma

Treatment Support Kit: Tivozanib

PQI in Action: Tivozanib (Fotivda®) for Relapse or Refractory Advanced Renal Cell Carcinoma

PQI: Revumenib (Revuforj) for the Management of Acute Leukemia

PQI: Talectrectinib (Ibtrozi) for the Management of ROS1+ Advanced NSCLC

S9 E1: Head & Neck Cancer Care: Clinical Progress & Compassionate Practice

Treatment Support Kit: Elranatamab